530233 Stock Overview
Manufactures and sells active pharmaceutical ingredients (APIs), intermediates, and generic formulations in India.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Auro Laboratories Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹170.00 |
| 52 Week High | ₹307.20 |
| 52 Week Low | ₹75.12 |
| Beta | 0.50 |
| 11 Month Change | -15.25% |
| 3 Month Change | -19.92% |
| 1 Year Change | 102.50% |
| 33 Year Change | 1.49% |
| 5 Year Change | 256.77% |
| Change since IPO | 8,152.43% |
Recent News & Updates
Recent updates
Shareholder Returns
| 530233 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | -0.8% | 2.2% | -1.0% |
| 1Y | 102.5% | 46.7% | 43.6% |
Return vs Industry: 530233 exceeded the Indian Pharmaceuticals industry which returned 46.7% over the past year.
Return vs Market: 530233 exceeded the Indian Market which returned 43.6% over the past year.
Price Volatility
| 530233 volatility | |
|---|---|
| 530233 Average Weekly Movement | 7.8% |
| Pharmaceuticals Industry Average Movement | 5.7% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in IN Market | 9.7% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: 530233's share price has been volatile over the past 3 months.
Volatility Over Time: 530233's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1989 | n/a | Sharat Deorah | www.aurolabs.com |
Auro Laboratories Limited manufactures and sells active pharmaceutical ingredients (APIs), intermediates, and generic formulations in India. It offers APIs for various drugs, such as antihistamine, muscle relaxant, diuretic, iron deficiency, anti-diabetic, anti-fungal, anti-ulcer, iodine supplement, anti-malaria, analgesics, antacids, and anti-inflammatory, as well as for other products, that includes potassium iodide, sodium iodide, and microcrystalline cellulose. The company also provides specialty chemicals comprising guanidine nitrate; dimethyl amine HCl; 2-ethoxy benzoic acid; and 3,4,5 - trimethoxy benzoic acid.
Auro Laboratories Limited Fundamentals Summary
| 530233 fundamental statistics | |
|---|---|
| Market cap | ₹1.06b |
| Earnings (TTM) | ₹77.92m |
| Revenue (TTM) | ₹536.35m |
13.6x
P/E Ratio2.0x
P/S RatioIs 530233 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 530233 income statement (TTM) | |
|---|---|
| Revenue | ₹536.35m |
| Cost of Revenue | ₹269.49m |
| Gross Profit | ₹266.86m |
| Other Expenses | ₹188.94m |
| Earnings | ₹77.92m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 12.50 |
| Gross Margin | 49.75% |
| Net Profit Margin | 14.53% |
| Debt/Equity Ratio | 62.5% |
How did 530233 perform over the long term?
See historical performance and comparison